Intrinsiqs

Is Oruka Therapeutics, Inc. overvalued?

Oruka Therapeutics, Inc. (ORKA) — key valuation metrics and fundamentals.

No verdict
Price
$106.81
Fair value
Current P/E
Normal P/E
Market cap
$6.44B
Dividend yield
18.5%
Return on equity
-26.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ORKA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.